Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00630"

PredicateValue (sorted: none)
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
drugbank:drugCategory
rdfs:label
"Alendronate"
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:drugCategory
owl:sameAs
drugbank:drugCategory
drugbank:interactsWith
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
owl:sameAs
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
drugbank:drugCategory
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
drugbank:description
"Alendronate is a nitrogen-containing, second generation bisphosphonate. Bisphosphonates were first used to treat Paget’s disease in 1971. This class of medications is comprised of inorganic pyrophosphate analogues that contain non-hydrolyzable P-C-P bonds. Similar to other bisphosphonates, alendronate has a high affinity for bone mineral and is taken up during osteoclast resorption. Alendronate inhibits farnesyl pyrophosphate synthetase, one of the enzymes in the mevalonic acid pathway involved in producing isoprenoid compounds that are essential for post-translational modification of small guanosine triphosphate (GTP)-binding proteins, such as Rho, Ras and Rab. Inhibition of this process interferes with osteoclast function and survival. Alendronate is used for the treatment of osteoporosis and Paget’s disease. "
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
owl:sameAs
drugbank:interactsWith
drugbank:interactsWith
drugbank:interactsWith
owl:sameAs
owl:sameAs
owl:sameAs
drugbank:interactsWith
rdf:type
owl:sameAs

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines2/drugbank_small.nt

The resource appears as object in 40 triples

Context graph